Having two doses of a COVID-19 vaccine has been linked with negative protection against symptomatic infection with the disease, scientists say, while a previous infection without vaccination offers around 50 percent immunity, according to a study analyzing the Omicron wave in Qatar.
The study, published in the New England Journal of Medicine on June 15, examined the Omicron wave in Qatar that occurred from around December 2021 to February 2022, comparing vaccination rates and immunity among more than 100,000 Omicron infected and non-infected individuals.
The authors of the study found that those who had a prior infection but no vaccination had a 46.1 and 50 percent immunity against the two subvariants of the Omicron variant, even at an interval of more than 300 days since the previous infection.
However, individuals who received two doses of the Pfizer and Moderna vaccine but had no previous infection, were found with negative immunity against both BA.1 and BA.2 Omicron subvariants, indicating an increased risk of contracting COVID-19 than an average person.
Over six months after getting two doses of the Pfizer vaccine, immunity against any Omicron infection dropped to -3.4 percent.
But for two doses of the Moderna vaccine, immunity against any Omicron infection dropped to -10.3 percent after more than six months since the last injection.
Though the authors reported that three doses of the Pfizer vaccine increased immunity to over 50 percent, this was measured just over 40 days after the third vaccination, which is a very short interval. In comparison, natural immunity persisted at around 50 percent when measured over 300 days after the previous infection, while immunity levels fell to negative figures 270 days after the second dose of vaccine.
These figures indicate a risk of waning immunity for the third vaccine dose as time progresses.
The findings are supported by another recent study from Israel that also found natural immunity waned significantly more slowly compared to artificial, or vaccinated, immunity.
The study found that both natural and artificial immunity waned over time.
Individuals that were previously infected but not vaccinated had half the risks of reinfection as compared to those that were vaccinated with two doses but not infected.
“Natural immunity wins again,” Dr. Martin Adel Makary, a public policy researcher at Johns Hopkins University, wrote on Twitter, referring to the Israeli study.
“Among persons who had been previously infected with SARS-CoV-2, protection against reinfection decreased as the time increased,” the authors concluded, “however, this protection was higher” than protection conferred in the same time interval through two doses of the vaccine.
Enrico Trigoso contributed to this report.
Therefore guard your minds, be sober, and hope to the end for the grace that is to be brought to you at the revelation of Jesus Christ. As obedient children do not conduct yourselves according to the former lusts in your ignorance. But as He who has called you is holy, so be holy in all your conduct, because it is written, “Be holy, for I am holy.” (1 Peter 1:13-16 Modern English Version)